Attached files
| file | filename |
|---|---|
| S-1MEF - FORM S-1MEF - Sage Therapeutics, Inc. | d909860ds1mef.htm |
| EX-5.1 - EX-5.1 - Sage Therapeutics, Inc. | d909860dex51.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of Sage Therapeutics, Inc., filed pursuant to Rule 462(b) of the Securities Act of 1933, of our report dated March 6, 2015 relating to the consolidated financial statements of Sage Therapeutics, Inc., which appears in Amendment No. 1 to the Registration Statement on Form S-1 (No. 333-203273). We also consent to the reference to us under the heading “Experts” in Amendment No. 1 to the Registration Statement on Form S-1 as incorporated by reference in this Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
April 14, 2015